Middle East and Africa Point-of-Care Diagnostics Market Growth Outlook Highlighted by Persistence Market Research

The Middle East and Africa (MEA) point-of-care (POC) diagnostics market has entered a pivotal phase of expansion as healthcare systems across the region shift toward decentralized testing, enhanced disease surveillance, and rapid clinical decision-making. With the market valued at US$ 2.7 billion in 2024 and projected to reach US$ 6.1 billion by 2031, the industry is set to expand at a strong CAGR of 12.3%. This momentum is primarily driven by the rising incidence of chronic and infectious diseases-especially diabetes, cardiovascular disorders, tuberculosis, HIV, and respiratory illnesses. Countries such as the United Arab Emirates, Saudi Arabia, and South Africa are witnessing alarming increases in conditions like Type 2 diabetes; in the UAE, for instance, diabetes affected 12.3% of the population in 2021, with prevalence expected to escalate to 21.4% by 2030, creating a pressing need for rapid and accurate testing.

Market performance is heavily influenced by the adoption of innovative diagnostics, integration of mobile health tools, and increasing government investments targeting healthcare modernization. Among the various market segments, infectious disease testing stands out as the leading product category, supported by significant government funding in disease management and surveillance. Meanwhile, prescription-based POC testing dominates the market by accounting for 65% of total demand in 2024, a trend propelled by clinical accuracy requirements and strict regulatory oversight. Geographically, the Kingdom of Saudi Arabia holds the largest share at 30%, driven by its sophisticated healthcare infrastructure and comprehensive national investment programs aimed at improving healthcare access and diagnostic speed.

Download Your Free Sample & Explore Key Insights: https://www.persistencemarketresearch.com/samples/34917

Key Highlights from the Report

• Kingdom of Saudi Arabia leads the MEA POC diagnostics market with a 30% share in 2024.
• Prescription-based POC testing commands 65% of total market share in 2024.
• Infectious disease testing products hold 30.9% of the market, supported by national disease-management programs.
• AI and machine learning adoption in POC analytics is opening new diagnostic possibilities.
• Development of POC tests for emerging diseases and personalized monitoring is accelerating.
• Growing acceptance of POC diagnostics for preventive healthcare is boosting long-term demand.

Market Segmentation

Market segmentation across the Middle East and Africa point-of-care diagnostics sector reflects a diverse range of products, testing modalities, and healthcare environments. Based on product type, the market encompasses infectious disease diagnostics, glucose monitoring, cardiometabolic testing, hematology, urinalysis, pregnancy and fertility tests, and coagulation assessments, among others. Among these categories, infectious disease diagnostics remains the dominant segment, fueled by the region's need for effective tools to combat viral, bacterial, and parasitic infections. The segment benefits from advancements in molecular diagnostic technologies, improved portability, and rising investment in disease monitoring programs by regional governments.

Segmentation by end-user includes hospitals, clinics, diagnostic centers, home care settings, and emergency medical services. Hospitals continue to serve as the primary users due to their capability to integrate sophisticated POC devices into emergency and inpatient workflows. Clinics and primary healthcare centers follow closely, as they are often the first point of interaction for patients seeking immediate care. Meanwhile, the home-care segment has expanded rapidly in recent years due to the growing prevalence of diabetes and hypertension, with patients seeking convenient and real-time monitoring solutions. Segmentation by prescription mode highlights the dominance of prescription-based diagnostics, which ensures clinical reliability, regulatory compliance, and professional interpretation of test results.

Regional Insights

The Middle East region leads in adoption of advanced point-of-care diagnostic technologies, largely due to high healthcare spending, strong digital transformation agendas, and government-led modernization initiatives. Saudi Arabia stands at the forefront with a 30% market share as of 2024, driven by robust investments under its national health strategy and increasing demand for rapid diagnostic solutions that reduce hospital burden. The United Arab Emirates and Qatar also demonstrate rapid uptake of POC devices, supported by their commitment to digital health, telemedicine integration, and personalized care models.

In Africa, growth is accelerating as governments seek to address chronic shortages in laboratory infrastructure. Countries such as South Africa, Kenya, Nigeria, Ghana, and Rwanda are emerging as high-potential markets due to increasing awareness of preventive health, rising disease burdens, and expanding mobile health networks. Sub-Saharan Africa continues to adopt POC devices as essential tools for infectious disease management, specifically in tuberculosis, malaria, and HIV screening-areas where timely diagnostics can significantly improve treatment outcomes. Rural regions are witnessing major improvements in healthcare access due to mobile diagnostic clinics and portable POC devices that eliminate the need for centralized laboratory analysis.

Get Custom Insights Designed for Your Business: https://www.persistencemarketresearch.com/request-customization/34917

Market Drivers

The Middle East and Africa POC diagnostics market is primarily driven by the rising prevalence of chronic and infectious diseases, which has heightened the demand for quick, accurate, and accessible diagnostic solutions. The surge in diabetes, cardiovascular conditions, and lifestyle-related disorders requires continuous monitoring, making POC devices indispensable for early detection and disease management. Additionally, recurrent outbreaks of infectious diseases such as COVID-19, tuberculosis, and HIV have forced health authorities to prioritize scalable and rapid testing solutions, further elevating the market's significance.

Another major driver is the urgent need for rapid diagnostics in regions with limited access to advanced laboratory facilities. In rural and remote communities, traditional lab-based testing often leads to delayed results, compromising timely treatment decisions. Point-of-care diagnostics effectively bridge this gap by providing immediate results, supporting triaging, and reducing patient load on centralized medical centers. Growing healthcare awareness, patient preference for convenience, and the push for decentralized healthcare models continue to boost POC adoption across both developed and emerging markets in the region.

Market Restraints

Despite promising growth, low healthcare spending in several parts of Africa and select Middle Eastern countries poses a considerable challenge to the widespread adoption of point-of-care diagnostics. While nations like Saudi Arabia and the UAE are heavily investing in healthcare modernization, many African countries struggle with limited budgets, inadequate infrastructure, and competing healthcare priorities. These limitations hinder the procurement of advanced POC devices, which often come with high upfront costs and significant maintenance requirements.

Additionally, the absence of robust reimbursement frameworks discourages healthcare providers from integrating POC solutions into routine practice. In low-income regions, governments often prioritize basic health services such as immunization, maternal care, and essential medicines over technologically advanced diagnostic tools. This imbalance slows market penetration and restricts the benefits of POC diagnostics to mainly urban and well-funded healthcare facilities. These constraints undermine the region's ability to adopt cutting-edge diagnostic innovations at the scale necessary to improve public health outcomes.

Market Opportunities

The most substantial opportunity in the Middle East and Africa POC diagnostics market lies in expanding molecular diagnostic capabilities to remote and underserved regions. These areas often lack advanced laboratory infrastructure, making POC technologies crucial for timely and accurate disease detection. Increasing investment in mobile health clinics, telemedicine, and portable diagnostic kits is enhancing the region's ability to diagnose infectious diseases, chronic illnesses, and emergency conditions in real time. Governments and global health organizations are increasingly collaborating to fund molecular POC systems that support disease control programs, maternal health initiatives, and rural healthcare access campaigns.

Another promising opportunity emerges from the rapid rise of telemedicine and mobile health platforms across the MEA region. Digital health adoption has accelerated dramatically, aided by expanding internet connectivity and smartphone penetration. When combined with POC diagnostics, these digital solutions allow real-time monitoring, faster clinical decisions, and remote consultation based on accurate test data. As governments and private healthcare providers invest heavily in virtual health ecosystems, integrating POC devices into these systems will redefine patient care pathways, reduce healthcare costs, and strengthen disease surveillance across the region.

Checkout Now & Download Complete Market Report: https://www.persistencemarketresearch.com/checkout/34917

Company Insights

Below is the list of companies operating actively in the Middle East and Africa Point-of-Care Diagnostics Market:

• QIAGEN
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• BD (Becton Dickinson)
• Abbott
• BIOMÉRIEUX
• Nova Biomedical
• Werfen
• Trividia Health, Inc.
• Siemens Healthcare Private Limited

Middle East and Africa Point-of-Care Diagnostics Market Segmentation

By Product

Infectious Disease
Glucose Monitoring
Hepatitis C
HIV Testing
Sexually Transmitted Disease (STD)
Influenza
Respiratory Infection
Tropical Disease
Healthcare-Associated Infection (HAI)
Pregnancy and Fertility
Tumor/Cancer Marker
Cardiometabolic
Cholesterol
Coagulation
Hematology
Urinalysis
Other Infectious Diseases

By Prescription Mode

Prescription-based
OTC

By Type

Consumables and Kits
Software and Services
Devices
Accessories

By End User

Hospitals
Ambulatory Care Settings
Home Care
Research Laboratories
Others

By Country

Kingdom of Saudi Arabia
United Arab Emirates
South Africa
Rest of Gulf Cooperation Council
Rest of the Middle East and Africa

Recent Developments

In January 2024, QIAGEN inaugurated its new regional headquarters in Riyadh, Saudi Arabia, and entered into a Memorandum of Understanding with the Ministry of Health to strengthen public health initiatives.

In September 2024, amplifAI health partnered with USATherm to integrate point-of-care thermal imaging technologies aimed at advancing disease monitoring capabilities across the region.

Conclusion

The Middle East and Africa point-of-care diagnostics market is undergoing a transformative shift fueled by an urgent need for accessible, rapid, and accurate testing solutions. With chronic and infectious diseases rising, governments and healthcare providers are prioritizing decentralized diagnostics to accelerate treatment decisions and enhance patient outcomes. The market's strong projected CAGR of 12.3% through 2031 reflects the expanding role of POC technologies in modern healthcare infrastructures. Although financial constraints in several regions pose challenges, ongoing investments in telemedicine, remote healthcare delivery, and molecular diagnostics are opening new pathways for market expansion. As digital health adoption accelerates and innovation continues to flourish, POC diagnostics are set to become the cornerstone of healthcare accessibility, disease management, and preventive care across the Middle East and Africa.

Read More Related Reports:

Cannabis Testing Services Market https://www.persistencemarketresearch.com/market-research/cannabis-testing-services-market.asp
Therapeutic Apheresis Market https://www.persistencemarketresearch.com/market-research/therapeutic-apheresis-market.asp
Cough Suppressant Market https://www.persistencemarketresearch.com/market-research/cough-suppressant-market.asp
Intracranial Aneurysm Market https://www.persistencemarketresearch.com/market-research/intracranial-aneurysm-market.asp

Contact Us:

Persistence Market Research
Second Floor, 150 Fleet Street, London, EC4A 2DQ, United Kingdom
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.